The data shows a gradual increase in hospital discharges for carcinoma in situ in Mexico from 2024 to 2028, with values rising from 3.55 thousand in 2024 to 3.78 thousand in 2028. This forecasted rise indicates an average year-on-year growth of approximately 1.67%. Based on the available historical data from 2023, where the value stood at 3.50 thousand, the trend is consistent with a steady increase. The Compound Annual Growth Rate (CAGR) over the five-year period (2024-2028) is roughly 1.65%.
Future trends to watch for include advancements in early detection and treatment, public health initiatives aimed at prevention, and changes in healthcare policies. These factors could influence both the incidence and hospitalization rates for carcinoma in situ in Mexico. Additionally, monitoring demographic shifts and lifestyle factors will be crucial in understanding and forecasting future trends.
